All insights
FDA PMS filePostmarket evidence cleanupSource review as of 2026-06-08

FDA PMS When a QA Team Needs an Inspection-Ready Monitoring File

When a quality owner is preparing a monitoring-file review, the problem is that public signals, internal complaints, service records, and owner decisions may not be connected. The useful output is a monitoring file map that keeps source facts, owner questions, and qualified-review boundaries visible.

TrueMedDevice can organize the file. It does not decide reportability, compliance, safety, effectiveness, enforcement risk, or inspection outcome.

For one quality owner before a monitoring-file review.

The scene

Picture the quality assurance manager in a QMSR readiness review before inspection planning. The team knows it should monitor recalls, adverse-event reports, and warning letters, but the file does not yet show how public signals connect to internal records.

The useful artifact is not a broad PMS summary. It is a monitoring file with source links, internal record references, open questions, owners, and next review triggers.

Monitoring file checklist

  • Public-source ledger with FDA recall, MAUDE, warning-letter, and database query details.
  • Comparator or product-family relevance note for each signal.
  • Internal evidence request: complaint trend, service record, CAPA screen, supplier note, risk-file link, or label review.
  • Owner, due date, rationale field, and next review trigger.
  • Decision boundary that keeps public signals separate from reportability, compliance, safety, and enforcement conclusions.

Inspection-ready output

OutputWhy it matters
Source ledgerShows what was checked and when.
Signal relevance notePrevents every public event from becoming a product conclusion.
Internal evidence mapLinks public signals to complaint, CAPA, risk, supplier, labeling, or management-review records.
Qualified-review queueNames what the QA, RA, legal, clinical, or leadership owner still needs to decide.

Source ledger

FDA Medical Device Recalls and Early Alerts

What it can tell you

Public FDA recall and early-alert records that can trigger review questions for a product family or comparator.

What it cannot decide

Recall applicability, root cause, reportability, risk acceptability, or quality-system action for a specific manufacturer.

FDA MAUDE adverse event database

What it can tell you

Public adverse-event report records that may inform signal review and internal evidence requests.

What it cannot decide

Causation, event rate, product defect, complaint disposition, reportability, or safety conclusions for a specific device.

FDA Warning Letters

What it can tell you

Public enforcement correspondence that can reveal inspection themes and quality-system review topics.

What it cannot decide

Whether another manufacturer has the same issue or whether one company's file has an enforcement risk.

Frequently asked questions

Does a MAUDE report prove a device caused an event?

No. MAUDE reports are public signals for review. They can be incomplete, duplicated, unverified, or missing exposure context.

What is the first useful output?

An FDA PMS monitoring file with public source ledger, internal evidence map, open review questions, owners, and next trigger.

Need the FDA PMS monitoring file organized?

Send the product family and inspection question. We can scope a source-backed monitoring file for qualified review.

Reader feedback

Useful pages should feed the next topic choices. Leave a signal or a short comment.

0 approved comments0 awaiting review
Comments are reviewed before they appear publicly. Keep it non-confidential and focused on what helped or what was still unclear.